Manage your Drug Discovery process

KMX Life Science Analytics enables companies to:

• Perform Intellectual Property (IP) searches and analytics
• Gain Competitor and customers insights through market research and data analytics
• Provide the right information to manage and measure a drug discovery strategy.
• Provide better insight in the company’s drug pipeline in order to optimize value of licensing IP (in and out).
• Report about drug discovery development and changes
• Landscaping using clustering and visualization technologies
• Improve Research effectiveness

In Life Sciences pharmaceutical drug discovery, source materials have been more uniform (scientific literature, clinical reports) and there is no need for real-time response, yet information volumes are huge and complex and the potential payoff using KMX Life Science Analytics – years and millions of euros or dollars shaved off lead-generation and clinical trials processes – is very significant.

Life science and healthcare companies have to operate in accordance with FDA regulations. The FDA has issued guidelines that determine quality control standards for the full pharmaceutical production process. For pharma companies this implies that they will have to measure every important parameter within their production process in order to control and optimize it.

KMX  provides a valuable insight in the production process. By applying data/ text mining techniques, generating all possible models from the data and analyzing all relationships between the models.

Using KMX Life Science Analytics enhances quality control of the production process, strongly improves production planning and saves production costs.

KMX Life Science Analytics can be used by clients in pharmaceutical, medtech, nutraceutical and chemical areas.